Drugs (Prices Control) Order, 1987

GlaxoSmithKline Pharmaceuticals Ltd., a manufacturer of the bulk drug Betamethasone Disodium Phosphate, was granted an exemption under paragraph 28 of the Drugs (Prices Control) Order, 1987, valid up to 31‑December‑1994. After the exemption expired, the Union of India issued a show‑cause notice alleging that the compan…

GlaxoSmithKline Pharmaceuticals Ltd challenged notices issued by the Drug Inspector after a price‑fixation notification under the Drugs (Prices Control) Order, 1995. The issue was whether the notified ceiling price became operative for all sales immediately, or whether manufacturers could continue to sell pre‑notificat…

Mentha & Allied Products Ltd manufactured menthol under a licence granted under the Drugs and Cosmetics Act and claimed exemption from central excise duty under Notification No. 31188‑CE, which exempts "bulk drugs" as defined in the Drugs (Prices Control) Order, 1987. The Central Excise Collector held that the menthol …